Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure

Semin Thromb Hemost. 2024 Mar;50(2):298-302. doi: 10.1055/s-0043-1772706. Epub 2023 Aug 23.

Authors

Giulia Simini¹, Frances Akor¹, Richard Szydlo¹, Michael Laffan^{1

2}, Deepa R J Arachchillage^{1

2}

Affiliations

¹ Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.
² Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.

PMID: 37611622
DOI: 10.1055/s-0043-1772706

No abstract available

MeSH terms

Anticoagulants / adverse effects
Blood Coagulation
Heparin* / adverse effects
Heparin, Low-Molecular-Weight
Humans
Renal Insufficiency* / drug therapy

Substances

Heparin
Anticoagulants
Heparin, Low-Molecular-Weight